Surgery Partners, Inc. $SGRY Stake Lessened by Voya Investment Management LLC

Voya Investment Management LLC lessened its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 86.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,842 shares of the company’s stock after selling 88,405 shares during the period. Voya Investment Management LLC’s holdings in Surgery Partners were worth $300,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of SGRY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Surgery Partners by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 45,693 shares of the company’s stock worth $1,085,000 after acquiring an additional 2,015 shares in the last quarter. Millennium Management LLC lifted its position in shares of Surgery Partners by 1,253.7% in the first quarter. Millennium Management LLC now owns 202,274 shares of the company’s stock worth $4,804,000 after purchasing an additional 219,806 shares in the last quarter. Twin Securities Inc. purchased a new stake in shares of Surgery Partners in the first quarter worth approximately $7,844,000. Caxton Associates LLP acquired a new stake in shares of Surgery Partners during the first quarter worth approximately $4,351,000. Finally, Empowered Funds LLC grew its position in Surgery Partners by 11.0% during the first quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock valued at $305,000 after purchasing an additional 1,278 shares in the last quarter.

Surgery Partners Price Performance

NASDAQ SGRY opened at $15.26 on Monday. Surgery Partners, Inc. has a fifty-two week low of $14.94 and a fifty-two week high of $26.16. The stock’s 50-day moving average is $17.26 and its two-hundred day moving average is $20.28. The firm has a market cap of $1.97 billion, a P/E ratio of -11.22 and a beta of 1.91. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.88 and a quick ratio of 1.72.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Monday, November 10th. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). Surgery Partners had a negative net margin of 5.21% and a positive return on equity of 2.41%. The company had revenue of $821.50 million for the quarter, compared to analyst estimates of $823.55 million. During the same period in the prior year, the company posted $0.19 EPS. The business’s revenue was up 6.6% on a year-over-year basis. On average, analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

SGRY has been the subject of a number of research analyst reports. Benchmark cut their target price on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating for the company in a research report on Tuesday, November 11th. UBS Group cut their price objective on Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, November 13th. JPMorgan Chase & Co. lowered their target price on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a research note on Monday, November 24th. Royal Bank Of Canada dropped their target price on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 11th. Finally, Mizuho lowered their price target on Surgery Partners from $22.00 to $19.00 and set an “outperform” rating for the company in a research note on Thursday, December 18th. Seven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Surgery Partners presently has an average rating of “Moderate Buy” and a consensus price target of $27.11.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.